Energies et Solutions photovoltaique
•
0 likes•131 views
A new study found that the COVID-19 vaccine developed by Pfizer and BioNTech is highly effective at preventing illness from the virus. The clinical trial involved over 40,000 participants and showed the vaccine was 95% effective starting one week after the second dose. The vaccine was found to work similarly well in people of different ages, ethnicities, and genders.
